HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High VEGF-D and Low MMP-2 Serum Levels Predict Nodal-Positive Disease in Invasive Bladder Cancer.

AbstractBACKGROUND:
To investigate stromal variables including angiogenesis, lymphangiogenesis, and matrix metalloproteinase (MMP) in the serum of patients with urothelial carcinoma of the bladder (UCB) and to evaluate their association with histopathological characteristics and clinical outcome.
MATERIAL AND METHODS:
Protein levels of vascular endothelial growth factors-A, -C, -D (VEGF-A/-C/-D), their receptors- VEGF-R2 and -R3 (VEGF-R2/-R3), and matrix metalloproteinases 2, -3, and -7 (MMP-2, MMP-3, MMP-7) were quantified in the blood serum samples of 71 patients with UCB before radical cystectomy (RC). Samples of patients with non-invasive UCB or no history of UCB were investigated as controls (n=20). Protein levels in the serum were measured using a flow cytometric cytokine assay.
RESULTS:
A positive association for VEGF-D (p<0.001) and an inverse association for MMP-2 (p=0.017) were observed in patients with positive lymph node (LN) status at the time of RC. VEGF-A (p<0.001), VEGF-C (p<0.001), MMP-2 (p<0.001), and MMP-7 (p=0.005) serum levels were different in serum of patients with invasive UCB compared with non-invasive UCB or healthy individuals. None of the serum markers were associated with disease progression.
CONCLUSIONS:
High VEGF-D and low MMP-2 serum levels predict LN metastasis in patients with UCB at the time of RC. VEGF-A, VEGF-C, MMP-2, and MMP-7 serum levels varied significantly between invasive and non-invasive disease as well as in comparison with healthy individuals. Clinical implementation of these marker serum measurements may be valuable to select high-risk patients with more invasive or nodal-positive disease.
AuthorsTobias Benoit, Etienne X Keller, Pirmin Wolfsgruber, Thomas Hermanns, Michele Günthart, Irina Banzola, Tullio Sulser, Maurizio Provenzano, Cédric Poyet
JournalMedical science monitor : international medical journal of experimental and clinical research (Med Sci Monit) Vol. 21 Pg. 2266-74 (Aug 04 2015) ISSN: 1643-3750 [Electronic] United States
PMID26241709 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • VEGFD protein, human
  • Vascular Endothelial Growth Factor D
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
Topics
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor (blood)
  • Case-Control Studies
  • Female
  • Humans
  • Lymphatic Metastasis
  • Male
  • Matrix Metalloproteinase 2 (blood)
  • Middle Aged
  • Neoplasm Invasiveness
  • Predictive Value of Tests
  • Prognosis
  • Urinary Bladder Neoplasms (blood, pathology, secondary)
  • Vascular Endothelial Growth Factor D (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: